Fundamental dimension Equity attribute | CEXEPeer $0.00010.00% Cap $6.51KP/E -0.0x QuantScore23/100 | DTTVYPeer $0.00010.00% Cap $184.1KP/E -0.4x QuantScore32/100 | GBXILeader $0.0006▼-73.91% Cap $354.5KP/E 0.4x QuantScore50/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
40/100 |
68/100 |
35/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 75/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 25/100 | 40/100 |
Growth Revenue / earnings growth & margins | 0/100 | 1/100 | 50/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.4x | 0.4x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -4.4x | -1.2x | -6.1x |
Price / Sales | — | 0.3x | — |
Price / Free Cash Flow | -0.0x | -13.8x | 0.1x |
PEG ratio | 0.00 | 0.01 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 2 / 9 | 2 / 9 |
Altman Z-Score | -378.73 (Distress) | — | -1000.97 (Distress) |
Total debt / equity | -0.60 | 0.00 | 0.00 |
Quick ratio | 0.0x | — | 0.3x |
Interest coverage | -3.4x | -2.2x | 163.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -22.0% | — |
Net income growth YoY | -81.8% | -74.2% | +257.3% |
Gross margin (TTM) | 0.0% | -17.9% | 0.0% |
Operating margin (FY) | — | -36.2% | — |
FCF margin (FY) | — | -1.3% | — |
5. Trailing price performancePrice change over period |
1M return | +0.0% | +0.0% | -64.7% |
3M return | +150.0% | +0.0% | -45.5% |
6M return | -97.5% | +0.0% | +200.0% |
Year to date | -97.5% | 0.0% | +100.0% |
1Y return | -97.5% | +0.0% | +500.0% |
3Y return | -97.5% | -99.8% | +200.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.2458 -245899.7% premium | $-0.0049 -5009.3% premium | $0.0001 -78.4% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |